Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma

By H. Onishi, T. Araki, H. Shirato, Y. Nagata, M. Hiraoka, K. Gomi, T. Yamashita, Y. Niibe, K. Karasawa, K. Hayakawa and 10 more. Cancer, 2004

875 citations recorded by the source corpus.

Subfields: Hepatology, Pulmonary and Respiratory Medicine, Radiation

View Paper: https://www.semanticscholar.org/paper/86a52c2f8e7b363252d4db61141b81155ffa7d93

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Fakiris
2. R. Mcgarry
3. R. Timmerman
4. C. Yiannoutsos
5. Mark D. Williams
6. M. Henderson

Citations in the corpus

• Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. (2009, background): “With a median follow-up of 24 months, the local progression rate was 14.5% (8.1% for BED $ 100 Gy vs. 26.4% for BED 27 ).”